Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRDM10-DT, also known as the putative uncharacterized protein encoded by LINC00167 or PRDM10 divergent transcript, is a long intergenic non-protein coding RNA (lincRNA) in Homo sapiens, mapped to gene symbols such as LINC00167 and C11orf37. According to UniProt, it is annotated as a "putative uncharacterized protein" but no definitive protein product or biological function has been validated. There is no evidence in reviewed literature for this being a therapeutic target, receptor, enzyme, transporter, or having any established cellular or disease functions. Unlike PRDM10, a characterized transcription factor involved in gene regulation and certain disease syndromes[1][2], PRDM10-DT refers to a transcript and not a canonical protein-coding gene or therapeutic target[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Putative uncharacterized protein encoded by LINC00167 (PRDM10-DT).